Cellebrite
CLBT
191 hedge funds and large institutions have $2.42B invested in Cellebrite in 2024 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 74 increasing their positions, 55 reducing their positions, and 18 closing their positions.
161% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 18
98% more call options, than puts
Call options by funds: $6.22M | Put options by funds: $3.14M
56% more capital invested
Capital invested by funds: $1.55B → $2.42B (+$865M)
35% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 55
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
16% more funds holding
Funds holding: 164 → 191 (+27)
8.45% more ownership
Funds ownership: 44.24% → 52.68% (+8.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$96.3M |
| 2 |
TWCM
True Wind Capital Management
San Francisco,
California
|
+$41M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$28.6M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$14.2M |
| 5 |
PP
Pertento Partners
London,
United Kingdom
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$16.4M |
| 2 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$13.9M |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$13.4M |
| 4 |
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Tel Aviv,
Israel
|
-$10M |
| 5 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$9.04M |
CLBT Hedge Fund Activity: Q4 2024 in Review
191 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q4 2024, worth a combined $2.42B — up 56% from $1.55B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new CLBT positions and 18 closed out — a net gain of 29 holders — while 74 added to existing stakes and 55 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $96.3M. The largest seller was Phoenix Financial, cutting an estimated $16.4M.
- 191 institutional investors held Cellebrite (CLBT) as of Q4 2024, up from 164 in Q3 2024.
- Funds reported $2.42B of Cellebrite stock for Q4 2024, up 56% quarter-over-quarter.
- 47 funds opened new Cellebrite positions in Q4 2024 and 18 closed out, a net change of +29 holders.
- The largest Cellebrite buyer in Q4 2024 was Fidelity Investments, an estimated $96.3M added.
- The largest Cellebrite seller in Q4 2024 was Phoenix Financial, an estimated $16.4M sold.
Based on aggregated 13F filings for Q4 2024.